Using immunohistochemical analysis of 92 tumor samples, we demonstrated that high KIF11 and low KIF14 expression correlate with poor patient outcomes, suggesting their combined evaluation offers superior prognostic value. The gene discussed is KIF14; the disease is neoplasm.